Home Members Research Professors

이름 : 김운기
연락처 : 02-880-2821
e-mail : og85403851@gmail.com
관심분야
Major Research interests

- Biochemistry and Molecular Biology
- Cellular immunology and Disease
- Stem cell (Mesenchymal and Hematopoietic stem cells)
약력
Feb 2011 Ph.D. Department of Life Science, Graduate School of Ulsan University.
 Feb 2004 M.Sc. Department of Immunology and Biomedicine, Graduate School of Ulsan University.
 Feb 2002 B.Sc Department of Microbiology, Graduate School of Ulsan University
연구업적
JOURNAL PUBLICATIONS

1. Hemeoxygenase-1 maintains bone mass via attenuating a redox imbalance in osteoclast.  Ke K, Safder MA, Sul OJ, KimWK, Suh JH, Joe Y, Chung HT, Choi HS.
Mol Cell Endocrinol. 2015 Jul 5;409:11-20. doi: 10.1016/j.mce.2015.03.022. Epub 2015 Apr 1. (Collaboration)

2. TNFRSF14 deficiency protects against ovariectomy-induced adipose tissue inflammation. Eun-Kyung Choi, Woon-KiKim, Ok-Joo Sul, Yun-Kyung Park, Eun-Sook Kim, Jae-Hee Suh, Rina Yu and Hye-Seon Choi, Journal of endocrinology 220(25) 2014.01.01. (Co 1STauthor)

3. Monocyte chemoattractant protein-1 deficiency attenuates oxidative stress and protects against ovariectomy-induced chronic inflammation in mice. Woon-KiKim, Eun-Kyung Choi, Ok-Joo Sul, Yeon-Kyung Park, Eun-Sook Kim, Rina Yu, Jae-Hee Suh, and Hye-Seon Choi, Plos one 8(8) 2013.08.19. (1STauthor)

4. Carbon monoxide protects against ovariectomy-induced bone loss by inhibiting osteoclastogenesis. Tien Van Phan, Ok-Joo Sul, Ke Ke, Mi-Hyun Lee, Woon-KiKim, Yeon-Soo Cho, Hyun-Ju Kim, Shin-Yoon Kim, Hun-Taeg Chung, Hye-Seon Choi, Biochem Pharmacol 85(8)2013.04.05. (Collaboration)

5. Overexpression of developmentally regulated GTP-binding protein-2 increases bone loss. Ke Ke , Ok-Joo Sul, Woon-Ki Kim, Mi-Hyun Lee , Myung-Seok Ko , Jae-Hee Suh , Hyun-Ju Kim , Shin-Yoon Kim, Jeong-Woo Park , Hye-Seon Choi, AJP-Endocrinology and Metabolism304(7) 2013.04.01. (Collaboration)

6. The elevation of fibrinogen due to loss of ovarian function enhances actin ring formation and leads to increased bone resorption. Ke k, KimWK, Sul OJ, Phan VT, Lee MH, Kim HJ, Kim SY, Choi HS. Am J Physiol Endocrinol Metab 2012, Sep 4. (Co 1STauthor)

7. Absence of Herpes Virus Entry Mediator (HVEM) Increases Bone Mass by Attenuating Receptor Activator of Nuclear Factor-kB ligand (RANKL)-Induced Osteoclastogenesis. KimWK, Sul OJ, Choi EK, Lee MH, Jeong CS, Kim HJ, kim SY, Suh JH, Yu R, Choi HS, Endocrinology 2012 153 (10).8.3. (1STauthor)

8. Platinum nanoparticles reduce ovariectomy-induced bone loss by  decreasing osteoclastogenesis. Woon-Ki Kim, Jin-Chun Kim,Hyun-Jung Park, Ok-Joo Sul, Mi-Hyun Lee, Ji-Soon Kim and Hye-Seon Choi. Exp Mol Med 2012 44(7): 432-439. (1STauthor)

9. Absence of MCP-1 leads to elevated bone mass via impaired actin ring formation.  OJ Sul, K Ke, WKKim, SH Kim, SC Lee, HJ Kim, SY Kim, JH Suh, HS Choi, J Cell Physiol. 2012 227(4):1619–1627. (Collaboration)

10. Curcumin protects against ovariectomy-induced bone loss and decreases osteoclastogenesis. WKKim, K Ke, OJ Sul, HJ Kim, SH Kim, MH Lee, HJ Kim, SY Kim, HT Chung, HS Choi1, J Cell Biochem. 2011 112(11):3159-3166. (1STauthor)

11. Role of TNFR-related 2 mediated immune responses in dextran sulfate sodium-induced inflammatory bowel disease. KimWK, Park JS, Sul OJ, Seo JH, Choi BK, Park HY, Latour AM, Koller BH, Kwon BS, Jeong CS. Mol Cells. 2011 31(2):99-104. (1STauthor)

12. Nuclear factor of activated T cells negatively regulates expression of the tumor necrosis factor receptor-related 2 gene in T cells. KimWK, Sul OJ, Kwak JS, Hur HY, Latour AM, Koller BH, Kwon BS, Jeong CS. Exp Mol Med. 2010 42(12):805-10. (1STauthor)

13. Regulation of the murine TR2/HVEM gene expression by IRF. Sul OJ, Lee HW, KimWK, Choi JH, Kwak JS, Choi YJ, Latour AM, Koller BH, Jeong CS, Kwon BS. Biochem Biophys Res Commun. 2008 367(2):277-83. (Collaboration)

PATENT APPLICATION

1. Application data : November 01. 2011
Applicant’s name: Foundation for Industry Cooperation, University of Ulsan, Korea (2-2005-014509-2)
Inventor name: Hye-Seon CHOI, Woon-Ki KIM, Ke K
Title of invention: Use of Fibrinogen as bone loss diagnostic marker

2. Application data : October 24.2011
Application number: 10-2011-0108928
Applicant’s name: Foundation for Industry Cooperation, University of Ulsan, Korea (2-2005-014509-2)
Inventor name: Hye-Seon CHOI, Jin-Chun Kim, Woon-Ki KIM, Ji-Soon Kim, Hyun-Jung Park
Title of invention: Composition for treating or preventing osteoporosis comprising platinum nanoparticle

3. Application data: October 24.2011
Application number: 10-2011-0108929
Applicant’s name: Foundation for Industry Cooperation, University of Ulsan, Korea (2-2005-014509-2)
Inventor name: Hye-Seon CHOI, Jin-Chun Kim, Woon-Ki KIM, Mi-Hyun Lee, Ji-Soon Kim
Title of invention: Composition for treating or preventing metabolic syndrome comprising platinum nanoparticle

4. Application data:  March 16. 2011.
Application number: 10-2011-0023155 (Receipt number 1-1-2011-0189935-67)
Applicant’s name: Foundation for Industry Cooperation, University of Ulsan, Korea (2-2005-014509-2)
Inventor name: Hye-Seon CHOI, Woon-Ki KIM, Eun Kyeong CHOI
Title of invention: Composition comprising carbon monoxide or carbon monoxide donor for preventing or treating menopausal syndrome

5. Application data: January 13. 2011.
Application number: 10-2011-0003522 (Receipt number 1-1-2011-0029209-20)
Applicant’s name: Foundation for Industry Cooperation, University of Ulsan, Korea (2-2005-014509-2)
Inventor name: Hye-Seon CHOI, Woon-Ki KIM, Eun Kyeong CHOI
Title of invention: Pharmaceutical composition for preventing or treating menopause comprising inhibitor of HVEM as active ingredient

6. Application data: November 30, 2010.
Applicant’s name: Foundation for Industry Cooperation, University of Ulsan, Korea (2-2005-014509-2)
Inventor name: Hye-Seon CHOI, Woon-Ki KIM, Choon Soo JEONG
Title of invention: Composition of osteogenic differentiation or osteogenesis comprising inhibitor of HVEM

7. Application data: September 30, 2010.
Applicant’s name: Foundation for Industry Cooperation, University of Ulsan, Korea (2-2005-014509-2)
Inventor name: Hye-Seon CHOI, Woon-KiKIM, Song Hee KIM
Title of invention: Composition comprising the curcumin for bone growth-promoting effects
목록